Jaydev Thakkar News Today

After visiting Biofourmis in Boston last year, OSP was impressed with the remote care the company could offer people from the comfort of their own homes.

An industry report released today forecasts that digital endpoints will see broader adoption in supporting pharmaceutical and life science label claims in the years ahead—but only after industry-wide, pre-competitive collaboration aimed at standardization and proactive sharing of data around clinically validated ...

Biofourmis, a leading global technology-enabled care delivery company, announced today the release of its expanded Digital Clinical Trials solution within the Biofourmis platform for biopharma and other life sciences companies. The solution offers robust digital tools and resources for trial sponsors and ...

Kuldeep Singh Rajput's departure comes just one month after the company laid off 120 employees.

Healthtech startup Biofourmis’ founder Kuldeep Singh Rajput has resigned from the position of chief executive officer abruptly. A Biofourmis spokesperson confirmed the development. The startup, which raised ......

In our first in-person event in two years, the MedCity INVEST conference March 28-30 at the Ritz Carlton Hotel in Chicago, there will be many opportunities to connect with startups, investors and potential collaboration partners.

The application window is open for the startup contest Pitch Perfect at INVEST March 28-30 at the Ritz Carlton in Chicago. Here's a look at some of the participants in the contest and progressed they've made on their mission to improve healthcare.

/PRNewswire/ -- Biofourmis, a Boston-based global leader in digital therapeutics and virtual care that powers personalized predictive care, has been named the...

An executive from the digital therapeutics specialist discusses the clinical trial landscape, and how clinical care can yield a number of important benefits.